(Q34293457)

1 August 2017

1 reference

title

Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment (English)

1 reference

1 August 2017

Van Den Neste E

1

1 reference

1 August 2017

Delannoy A

2

1 reference

1 August 2017

Feremans W

3

1 reference

1 August 2017

Ferrant A

4

1 reference

1 August 2017

Michaux L

5

1 reference

1 August 2017

1 February 2001

1 reference

1 August 2017

1 reference

1 August 2017

40

1 reference

1 August 2017

541-550

1 reference

1 August 2017

5-6

1 reference

Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis

1 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

2-Chlorodeoxyadenosine inhibits the repair of DNA double-strand breaks and does not inhibit the repair of DNA single-strand breaks in X-irradiated Chinese hamster V79 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Second cancers in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Second malignancies following treatment in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Hodgkin's disease variant of Richter's syndrome: experience at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Paradoxical immunologic effects of 2-CdA therapy: comment on the article by Davis et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097653

10.3109/10428190109097653

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference